Galmed Pharmaceuticals (Galmed Pharmaceuticals) Price-to-Tangible-Book : 0.14 (As of Apr. 26, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-04-26), Galmed Pharmaceuticals's share price is $0.3925. Galmed Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $2.75. Hence, Galmed Pharmaceuticals's Price to Tangible Book Ratio of today is 0.14.

The historical rank and industry rank for Galmed Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

GLMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.13 Med: 1.69 Max: 8.36
Current: 0.14

During the past 12 years, Galmed Pharmaceuticals's highest Price to Tangible Book Ratio was 8.36. The lowest was 0.13. And the median was 1.69.

GLMD's Price-to-Tangible-Book is ranked better than
98.93% of 1220 companies
in the Biotechnology industry
Industry Median: 2.68 vs GLMD: 0.14

A closely related ratio is called PB Ratio. As of today, Galmed Pharmaceuticals's share price is $0.3925. Galmed Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was $2.75. Hence, Galmed Pharmaceuticals's P/B Ratio of today is 0.14.

Galmed Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Galmed Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Price-to-Tangible-Book Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.75

1.50

0.94

0.17

Galmed Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.94	0.90	0.48	0.16	0.17

Competitive Comparison of Galmed Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Galmed Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galmed Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Price-to-Tangible-Book falls into.

Galmed Pharmaceuticals Price-to-Tangible-Book Calculation

Galmed Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.3925	/	2.751
	=	0.14

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Galmed Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Galmed Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Galmed Pharmaceuticals (Galmed Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (NAS:GLMD) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

GPH:Germany

Address

16 Tiomkin Street, Tel Aviv, ISR, 6578317

Website

https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.